Rigel Pharmaceuticals, Inc.
448 articles about Rigel Pharmaceuticals, Inc.
-
After Slashing Jobs, Rigel Brings Aboard Two R&D Execs
10/7/2016
-
Why Rigel's Layoffs May Not be a Bad Thing
9/19/2016
-
Bay Area's Rigel Slashes 38% of Workforce; Shifts From R&D to Commercial Operation
9/16/2016
-
Rigel's Bleeding Disorder Drug Passes First of Two Key Late-Stage Trials
8/30/2016
-
Rigel Announces Press Release And Conference Call Schedule On Tuesday, August 30, 2016
8/30/2016
-
Rigel Announces Second Quarter 2016 Financial Results And Provides Portfolio Update
8/3/2016
-
Rigel Announces Conference Call And Webcast To Report Second Quarter 2016 Financial Results
7/26/2016
-
Rigel To Present At Jefferies 2016 Healthcare Conference
6/2/2016
-
Rigel To Present At Upcoming American Association Of Immunologists (AAI) Annual Meeting
5/5/2016
-
Rigel Announces First Quarter 2016 Financial Results
5/4/2016
-
Rigel Announces Conference Call And Webcast To Report First Quarter 2016 Financial Results
4/26/2016
-
Rigel Announces Presentations At Upcoming AACR Conference
4/12/2016
-
Rigel Completes Enrollment Of FIT Phase 3 Program For Fostamatinib In ITP
4/1/2016
-
Rigel Names Anne-Marie Duliege, M.D., M.S. As Chief Medical Officer
3/9/2016
-
Rigel Announces Fourth Quarter And Year End 2015 Financial Results
3/9/2016
-
Rigel Announces Conference Call And Webcast To Report Fourth Quarter And Year End 2015 Financial Results
3/1/2016
-
Rigel To Present At Cowen and Company 36th Annual Health Care Conference
2/29/2016
-
Rigel Initiates Phase 2 Clinical Trial Of Fostamatinib In Autoimmune Hemolytic Anemia
2/25/2016
-
Rigel Completes Enrollment Of First Phase 3 Study Of Fostamatinib In ITP (FIT)
1/28/2016
-
Rigel Reviews Recent Progress And Announces Presentation At The 34th Annual J.P. Morgan Healthcare Conference In San Francisco
1/7/2016